CDKN1A and pancreatic neoplasm: This finding aligns with a previous report by Kazuto Nishio et al., which demonstrated that homozygous deletion of ACVR1B in pancreatic cancer cell lines may promote an aggressive cancer phenotype by influencing SMAD2 phosphorylation and p21CIP1/WAF1 expression levels (20).